Torsin2A inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of the Torsin2A protein, a component involved in various cellular pathways. These inhibitors work by binding to the active site of the Torsin2A protein, preventing the natural substrates or ligands from accessing this site and thereby disrupting its biological activity. By occupying the active site, Torsin2A inhibitors block the protein's role in its associated biochemical processes. In addition to active-site inhibition, some Torsin2A inhibitors may bind to allosteric sites located away from the active site, causing conformational changes in the protein that reduce or abolish its function. These inhibitors rely on a variety of non-covalent interactions, including hydrogen bonding, van der Waals forces, hydrophobic contacts, and ionic interactions, to achieve stable and effective binding to the Torsin2A protein.
The structural design of Torsin2A inhibitors is characterized by a wide range of molecular frameworks, allowing for specific interactions with different regions of the protein. These inhibitors often contain functional groups such as hydroxyl, amine, or carboxyl groups, which enable them to form key hydrogen bonds with amino acid residues in the protein's active or allosteric sites. Additionally, hydrophobic regions within the inhibitors interact with non-polar areas of the Torsin2A protein, further stabilizing the inhibitor-protein complex. Many Torsin2A inhibitors feature aromatic rings or heterocycles, which can enhance binding through π-π stacking interactions with aromatic residues in the protein. The physicochemical properties of Torsin2A inhibitors, such as molecular weight, polarity, solubility, and lipophilicity, are carefully optimized to ensure proper binding and stability in diverse biological environments. By balancing hydrophobic and hydrophilic regions, Torsin2A inhibitors are designed to effectively modulate the activity of the protein while maintaining structural stability and functionality.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Hsp90 inhibitor, leads to the degradation of client proteins and could affect Torsin2A if it relies on Hsp90 for folding or stability. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Inhibits proteasomal activity, could lead to increased cellular stress affecting Torsin2A turnover if it is prone to ubiquitination. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
Cyclin-dependent kinase inhibitor, could disrupt cell cycle regulation thereby influencing Torsin2A activity if it's cell cycle-dependent. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
SERCA pump inhibitor, leads to increased cytosolic calcium levels, could affect Torsin2A if it is calcium-sensitive. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, could prevent the degradation of misfolded Torsin2A proteins, affecting cellular homeostasis. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor, similar to Bortezomib, could stabilize Torsin2A if it is normally ubiquitinated and degraded. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
Aurora kinase inhibitor, could disrupt mitotic processes and influence Torsin2A if it plays a role in mitosis. | ||||||
PD 150606 | 179528-45-1 | sc-222133 sc-222133A | 5 mg 25 mg | $116.00 $395.00 | 18 | |
Calpain inhibitor, prevents calcium-dependent proteolysis and could maintain Torsin2A levels if it is a calpain substrate. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK pathway inhibitor, could modulate stress responses and affect Torsin2A if it is involved in stress-related signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, could alter inflammatory response pathways and impact Torsin2A activity if it is part of such pathways. | ||||||